Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle

Veterinary Therapeutics

Volumn 7, Issue 4, 2006, Pages 347-360

  Coetzee, Johann F ^a   Apley, Michael D ^a,c   Kocan, Katherine M ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASMA MARGINALE; ANIMALIA; BOS;

ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; ENROFLOXACIN; IMIDOCARB; OXYTETRACYCLINE; QUINOLONE DERIVATIVE;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; COMPARATIVE STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HEMATOCRIT; HETEROZYGOTE; MICROBIOLOGY; POLYMERASE CHAIN REACTION; RANDOMIZATION; SPLENECTOMY; TIME;

ANAPLASMA MARGINALE; ANAPLASMOSIS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; CARRIER STATE; CATTLE; CATTLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FLUOROQUINOLONES; HEMATOCRIT; IMIDOCARB; OXYTETRACYCLINE; POLYMERASE CHAIN REACTION; RANDOM ALLOCATION; SPLENECTOMY; TIME FACTORS;

EID: 33947547068     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Uilenberg G: International collaborative research, significance of tick-borne hemoparasitic diseases to world animal health. Vet Parasitol 57:19-41, 1995.
2. Dumler JS, Barbet AF, Bekker CPJ, et al: Reorganization of genera in the families Rickettsiaceae and Anaplasmataceac in the order Rickettsiales, unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 51:2145-2165, 2001.
3. Kocan KM, de la Fuente J, Guglielmone AA, Melendez RD: Antigens and alternatives for control of Anaplasma marginale infection in cattle. Clin Microbiol Rev 16:698-712, 2003.
4. Potgieter FT, Stoltsz WH: Anaplasmosis, in Coetzer JAW, Thompson GR, Tustin RC (eds): Infections Diseases of Livestock With Special Reference to Southern Africa. Cape Town, Oxford University Press, 2004, pp 408-430.
5. Kuttler KL, Simpson JE: Relative efficacy of two oxytetracycline formulations and doxycycline in the treatment of acute anaplasmosis in splenectomized calves. Am J Vet Res 39(2):347-349, 1978.
6. Stewart CG, Immelman A, Grimbeek P, Grib D: The use of a short and long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves. J South Afr Vet Assoc 50:83-85, 1979.
7. Magonigle RA, Newby TJ: Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable. Am J Vet Res 43(12):2170-2172, 1982.
8. Roby TO, Simpson JE, Amerault TE: Elimination of the carrier state of bovine anaplasmosis with a longacting oxytetracycline. Am J Vet Res 39(7):1115-1116, 1978.
9. th Annu Meet USAHA:73-82, 1980.
10. Kuttler KL: Influence of a second Anaplasma exposure on the success of the treatment to eliminate Anaplasma carrier infections in cattle. Am J Vet Res 44(5):882-883, 1983.
11. Swift BL, Thomas GM: Bovine anaplasmosis: Elimination of the carrier state with injectable long-acting oxytetracycline. JAVMA 183(1):63-65, 1983.
12. Rogers RJ, Dunster PJ:The elimination of Anaplasma marginale from carrier cattle by treatment with long acting oxytetracycline. Aust Vet J 61(9):306, 1984.
13. Ozlem MB, Karaer Z, Turgut K, et al: Efficacy of long-acting oxytetracycline on bovine anaplasmosis. AÜ Vet Fak Derg35(1):1-5, 1988.
14. Coetzee JF, Apley MD, Kocan KM, et al: Comparison of three oxytetracycline regimens for the treatment of persistent Anaplasma marginal: infections in beef cattle. Vet Parasitol 127:61-73, 2005.
15. th World Vet Cong.60, 1991.
16. Guglielmone AA, Anziani OS, Mangold AJ, et al: Enrofloxacin to control Anaplasma marginale infections. Ann NY Acad Sci 791:471-472, 1996.
17. Roby TO, Mazzola V: Elimination of the carrier state of bovine anaplasmosis with imidocarb. Am J Vet Res 33(10):1931-1933, 1972.
18. Torioni De Echaide S, Knowles DP, McGuire TC, et al: Detection of cattle naturally infected with Anaplasma marginale by nested PCR and a competitive enzyme-linked immunosorbent assay using recombinant Major Surface Protein 5. J Clin Micro 36(3):777-782, 1998.
19. 18a. Coetzee JF, Apley MD, Kocan KM, Jones DE: Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures. J Vet Phannacol Ther 29:173-183, 2006.
20. Office International des Epizooties (OIE): Bovine anaplasmosis, in Manual of Standards for Diagnostic Tests and Vaccines for Terrestrial Animals, ed 5. Accessed September 2006 at www.oie.int/eng/normes/mmanual/ A_00058.htm.
21. Veterinary Medical Research & Development (VMRD): Anaplasma Antibody Test Kit, cELISA. Accessed September 2006 at http://www.vmrd.com/docs/tk/ Anaplasma/Anaplasma_2_and_5-plate_circular_060505.pdf.
22. Thompson JR, Kersting KW, Wass WM, et al: Splenectomy in cattle via transthoracic approach. Am J Vet Res 53(1):143-l44, 1992.
23. Foote LE, Farley H, Wulf M: The spleen and anaplasmosis. North Am Vet Dec:827-828, 1951.
24. Everitt BS: The analysis of repeated measures: A practical reviewwidiexamples. Statistician 44(1):113-135, 1995.
25. Everitt BS, Dunn G: Applied Multivariate Data Analysis. London, Arnold, 2001.
26. Hayter AJ: A proof of the conjecture that the Tukey-Kramer multiple comparisons procedure is conservative. Ann Math Stat 12:61-75, 1984.
27. Compendium of Veterinary Products, ed 8. Port Huron, MI, North American Compendiums, 2005.
28. McHardy N, Simpson RM: Imidocarb dipropionate therapy in Kenyan anaplasmosis and babesiosis. Trop Anim Health Prod 6:63-70, 1974.
29. Adams LG, Corner DE: A study of the toxicity of imidocarb dipropionate in cattle. Res Vet Sci 28:172-177, 1980.
30. Magonigle RA, Renshaw HW, Vaughn HW, et al: Effect of five daily treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis. JAVAMA 167(12):1080-1083, 1975.
31. de la Fuente J, Van Den Bussche RA, Kocan K: Molecular phylogeny and biogeography of North American isolates of Anaplasma marginale (Rickettsiaceae, Ehrlichieae). Vet Parasitol 97:65-76, 2001.
32. Palmer GH, Knowles DP, Rodriguez JL, et al: Stochastic transmission of multiple genotypically distinct Anaplasma marginale strains in a herd with high prevalence of Anaplasma infection. J Clin Microbiol 42: 5381-5384, 2005.
33. Brayton KA, Kappmeyer LS, Herndon DR, et al: Complete genome sequencing of Anaplasma marginale reveals that the surface is skewed to two superfamilies of outer membrane proteins. Proc Nat Acad Sci USA 102(3):844-849, 2005.
34. Maurin M, Dakken JS, Dumler JS: Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother 47(1):413-415, 2003.
35. Goff WL, Stiller D, Roeder RA, et al: Comparison of a DNA probe, complement-fixation and indirect immunofluorescence tests for diagnosing Anaplasma marginalem suspected carrier cattle. Vet Microbiol 24: 381-390, 1990.